Chris Hayes @chrislhayes
RT @rob_carlson: This. This. This. IP is not the issue. It’s all about manufacturing AND correctly transferring tricky processing info for… — PolitiTweet.org
Kathryn Brightbill ✒️ @KEBrightbill
Simplifying it to being an IP issue when both Moderna and AstraZeneca-Oxford's vaccines can be manufactured without… https://t.co/Eugpr4C3cZ